Cargando…
Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay
The COVID-19 pandemic caused by SARS-CoV-2 is an unprecedentedly significant health threat, prompting the need for rapidly developing antiviral drugs for the treatment. Drug repurposing is currently one of the most tangible options for rapidly developing drugs for emerging and reemerging viruses. In...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
National Academy of Sciences
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325362/ https://www.ncbi.nlm.nih.gov/pubmed/34234012 http://dx.doi.org/10.1073/pnas.2024302118 |